Basit öğe kaydını göster

dc.contributor.authorTuran, Belma
dc.contributor.authorTuncay, Erkan
dc.date.accessioned2021-06-11T07:40:46Z
dc.date.available2021-06-11T07:40:46Z
dc.date.issued2021-02-01
dc.identifier.other33225416
dc.identifier.urihttp://hdl.handle.net/20.500.12591/580
dc.description.abstractAn important energy supplier of cardiomyocytes is mitochondria, similar to other mammalian cells. Studies have demonstrated that any defect in the normal processes controlled by mitochondria can lead to abnormal ROS production, thereby high oxidative stress as well as lack of ATP. Taken into consideration, the relationship between mitochondrial dysfunction and overproduction of ROS as well as the relation between increased ROS and high-level release of intracellular labile Zn, those bring into consideration the importance of the events related with those stimuli in cardiomyocytes responsible from cellular Zn-homeostasis and responsible Zn-transporters associated with the Zn-homeostasis and Zn-signaling. Zn-signaling, controlled by cellular Zn-homeostatic mechanisms, is regulated with intracellular labile Zn levels, which are controlled, especially, with the two Zn-transporter families; ZIPs and ZnTs. Our experimental studies in mammalian cardiomyocytes and human heart tissue showed that Zn-transporters localizes to mitochondria besides sarco(endo)plasmic reticulum and Golgi under physiological condition. The protein levels as well as functions of those transporters can re-distribute under pathological conditions, therefore, they can interplay among organelles in cardiomyocytes to adjust a proper intracellular labile Zn level. In the present review, we aimed to summarize the already known Zn-transporters localize to mitochondria and function to stabilize not only the cellular Zn level but also cellular oxidative stress status. In conclusion, one can propose that a detailed understanding of cellular Zn-homeostasis and Zn-signaling through mitochondria may emphasize the importance of new mitochondria-targeting agents for prevention and/or therapy of cardiovascular dysfunction in humans.en_US
dc.language.isoengen_US
dc.publisherTıp Fakültesien_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectAgingen_US
dc.subjectHearten_US
dc.subjectHyperglycemiaen_US
dc.subjectHyperinsulinemiaen_US
dc.subjectMitochondriaen_US
dc.subjectZincen_US
dc.subjectZinc-transportersen_US
dc.titleThe role of labile Zn and Zn-transporters in the pathophysiology of mitochondria dysfunction in cardiomyocytes.en_US
dc.typeinfo:eu-repo/semantics/articleen_US
dc.contributor.departmentTemel Tıp Bilimlerien_US


Bu öğenin dosyaları:

Thumbnail
Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

info:eu-repo/semantics/openAccess
Aksi belirtilmediği sürece bu öğenin lisansı: info:eu-repo/semantics/openAccess